Rosuvastatin Completed Phase 0 Trials for Friedreich's Ataxia Treatment

IndicationsStatusPurposePhase
CompletedTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT02705547Rosuvastatin (Crestor) in Friedreich Ataxia